Small cerebral vascular disease
Conditions
Interventions
control group:2 placebo capsules once, twice a day
experimental group:Xuesaitong soft capsule is taken orally, twice a day, two capsules each time
Sponsors
The First Clinical Medical College of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: ? Outpatient or inpatient patients aged 50-80 years old and elderly residents in the community, regardless of gender, education level =6 years; ? Meet the diagnostic criteria of Western medicine and Chinese medicine; ? no history and signs of stroke; ? Willing to be randomly assigned to the test group and the control group; ? Volunteer to participate in the experiment and sign the informed consent.
Exclusion criteria
Exclusion criteria: ? Patients with severe heart, liver and kidney insufficiency; ? Patients with other mental and nervous system diseases and malignant tumors; ? Participants who had participated in other drug trials within three months before enrollment; ? Poor compliance or life-threatening can not complete the course of treatment; ? Use of other cognitive-improving drugs such as ChEIs or other psychotropic drugs within the last three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood pressure;Multi-domain cognitive function scores;MMSE Score;Fazekas score; | — |
Countries
China
Contacts
Public ContactZhao Xiao Dong
Dongzhimen Hospital
Outcome results
None listed